Financial Information of Asston Pharmaceuticals Limited IPO
The Revenues from operations for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 620.93, ₹ 2,561.02 Lakh, ₹ 1,584.09 Lakh and ₹ 719.19 Lakh. The EBITDA for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 194.90, ₹ 673.03 Lakh, ₹
280.06 Lakh and ₹ 217.05 Lakh. The Profit after Tax for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 132.24, ₹
432.51 Lakh, ₹ 136.03 Lakh and ₹ 105.66 Lakh respectively. This indicates a steady growth in financial performance.
| Period Ended | May 31, 2025 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|---|
| Reserve of Surplus | 576.87 | 444.63 | 560.86 | 128.59 |
| Total Assets | 3,183.43 | 2,812.26 | 2,026.02 | 1,369.42 |
| Total Borrowings | 783.28 | 725.72 | 681.99 | 524.51 |
| Fixed Assets | 93.44 | 95.56 | 109.10 | 113.14 |
| Cash | 21.50 | 19.91 | 0.64 | 12.37 |
| Net Borrowing | 761.78 | 705.81 | 681.35 | 512.14 |
| Revenue | 620.93 | 2,561.02 | 1,584.09 | 719.19 |
| EBITDA | 194.90 | 673.03 | 280.06 | 217.05 |
| PAT | 132.24 | 432.51 | 136.03 | 105.66 |
| EPS | 2.11 | 6.9 | 2.37 | 1.89 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Copyright @2020 Design & Developed by Info Web Software